ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,042, issued on Nov. 3, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).
"ERK5 degraders and uses thereof" was invented by Inchul You (Boston), Eric Wang (Brookline, Mass.) and Nathanael S. Gray (Stanford, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described are the bifunctional compounds, compositions and methods of treating a disease or disorder characterized by aberrant extracellular-signal-regulated kinase 5 (ERK5) activity."
The patent was filed on Sept. 19, 2022, under Application No. 18/691,268.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...